Literature DB >> 19013209

Atypical neuroleptic risperidone modulates glial functions in C6 astroglial cells.

André Quincozes-Santos1, Larissa Daniele Bobermin, Juliana Kleinkauf-Rocha, Diogo Onofre Souza, Rudimar Riesgo, Carlos-Alberto Gonçalves, Carmem Gottfried.   

Abstract

Risperidone has demonstrated therapeutic advantages over conventional neuroleptics and offers a valuable emerging option for the treatment of social behavior associated with autistic disorder. Considering the putative involvement of astroglial cells in neuropsychiatric disorders, we investigated the effect of risperidone on parameters of astrocyte activity - glutamate uptake, glutamine synthetase (GS) activity and glutathione (GSH) levels. Risperidone was able to induce a significantly increase on glutamate uptake (32%); GS activity (15%); GSH levels (58%). These findings imply the perspectives for further investigations directed on astrocytes from different brain areas. Our present results suggest that risperidone might exert its neuroprotective effects against brain illness at least partially via modulation of astrocyte functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013209     DOI: 10.1016/j.pnpbp.2008.08.023

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  8 in total

1.  Methylglyoxal alters glucose metabolism and increases AGEs content in C6 glioma cells.

Authors:  Fernanda Hansen; Daniela Fraga de Souza; Simone da Luz Silveira; Ana Lúcia Hoefel; Júlia Bijoldo Fontoura; Ana Carolina Tramontina; Larissa Daniele Bobermin; Marina Concli Leite; Marcos Luiz Santos Perry; Carlos Alberto Gonçalves
Journal:  Metab Brain Dis       Date:  2012-07-18       Impact factor: 3.584

Review 2.  Monoaminergic Control of Cellular Glucose Utilization by Glycogenolysis in Neocortex and Hippocampus.

Authors:  Mauro DiNuzzo; Federico Giove; Bruno Maraviglia; Silvia Mangia
Journal:  Neurochem Res       Date:  2015-07-14       Impact factor: 3.996

3.  Paliperidone regulates intracellular redox system in rat brain: Role of purine mechanism.

Authors:  Kadir Demirci; Ramazan Özçankaya; H Ramazan Yilmaz; Ayşe Yiğit; Abdülhadi Cihangir Uğuz; Kadir Karakuş; Arif Demirdaş; Abdullah Akpınar
Journal:  Redox Rep       Date:  2014-12-29       Impact factor: 4.412

4.  Glioprotective Effect of Resveratrol: an Emerging Therapeutic Role for Oligodendroglial Cells.

Authors:  Priscila Machado Rosa; Leo Anderson Meira Martins; Diogo Onofre Souza; André Quincozes-Santos
Journal:  Mol Neurobiol       Date:  2017-04-29       Impact factor: 5.590

Review 5.  A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder.

Authors:  Sushmitha S Purushotham; Neeharika M N Reddy; Michelle Ninochka D'Souza; Nilpawan Roy Choudhury; Anusa Ganguly; Niharika Gopalakrishna; Ravi Muddashetty; James P Clement
Journal:  Exp Brain Res       Date:  2022-09-05       Impact factor: 2.064

6.  Effects of atypical (risperidone) and typical (haloperidol) antipsychotic agents on astroglial functions.

Authors:  André Quincozes-Santos; Larissa Daniele Bobermin; Rafaela Pestana Leques Tonial; Victorio Bambini-Junior; Rudimar Riesgo; Carmem Gottfried
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-12-30       Impact factor: 5.270

7.  Brain findings associated with risperidone in rhesus monkeys: magnetic resonance imaging and pathology perspectives.

Authors:  Guillermo Fernandez; Sabu Kuruvilla; Catherine D G Hines; Frédéric Poignant; James Marr; Thomas Forest; Richard Briscoe
Journal:  J Toxicol Pathol       Date:  2019-05-13       Impact factor: 1.628

Review 8.  Gliotoxicity and Glioprotection: the Dual Role of Glial Cells.

Authors:  André Quincozes-Santos; Camila Leite Santos; Rômulo Rodrigo de Souza Almeida; Amanda da Silva; Natalie K Thomaz; Naithan Ludian Fernandes Costa; Fernanda Becker Weber; Izaviany Schmitz; Lara Scopel Medeiros; Lívia Medeiros; Bethina Segabinazzi Dotto; Filipe Renato Pereira Dias; Vanessa Sovrani; Larissa Daniele Bobermin
Journal:  Mol Neurobiol       Date:  2021-09-28       Impact factor: 5.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.